OTC · Drug Manufacturers - General

Haw Par Corporation Limited (HAWPF) Stock

$12.58 +4.79% OTC: HAWPF Healthcare

Haw Par Corporation Limited, a company established in 1969 and headquartered in Singapore, conducts a broad range of operations including the manufacturing, marketing, and distribution of healthcare products across Singapore, ASEAN countries, other parts of Asia, and international markets. Its business activities are structured into three main segments: 1.

Valuation

MetricValue
Price$12.58
Market Cap$2.78B
P/E Ratio13.52
P/B Ratio0.84
P/S Ratio15.61
EPS (TTM)$0.93
52-Week High$14.17
52-Week Low$9.40
Dividend Yield1.27%

Financials & Margins

MetricValue
ROE6.34%
ROA6.01%
ROCE1.56%
Gross Margin55.99%
Operating Margin29.17%
Net Margin115.43%
Debt/Equity0.01
Current Ratio7.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$141.0M$182.0M$232.0M$245.0M$230.0M
Operating Profit$25.0M$43.0M$64.0M$64.0M$67.0M
Net Profit$110.0M$148.0M$217.0M$228.0M$265.0M
EPS$0.50$0.67$0.98$1.03$1.20
Op Margin17.5%23.8%27.6%26.1%29.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.3B$3.6B$3.6B$4.3B$4.4B
Total Liabilities$72.0M$101.0M$117.0M$128.0M$127.0M
Cash$596.0M$334.0M$574.0M$746.0M$791.0M
Borrowings$2.0M$58.0M$28.0M$36.0M$44.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$19.0M$41.0M$63.0M$54.0M$271.0M
Investing Cash Flow$83.0M$-281.0M$250.0M$196.0M$75.0M
Financing Cash Flow$0$-1.0M$-2.0M$-2.0M$0
Net Cash Flow$42.0M$-262.0M$240.0M$172.0M$89.0M
Free Cash Flow$14.0M$21.0M$55.0M$50.0M$269.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.82
EV / EBITDA38.71
FCF Yield4.21%
Quick Ratio6.96
Interest Coverage44.05
Return 1Y29.35%
Return 3Y103.74%
Return 5Y—

Ownership

Insiders Held38.64%
Institutions Held19.35%
Institutions Float Held31.54%
Institutional HolderSharesReport Date
First Eagle Funds-First Eagle Overseas Fund17,062,8132026-04-30
Virtus Opportunities Trust-Virtus KAR International Small-Mid Cap Fund3,915,0122026-03-31
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1,923,8002026-04-30
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund1,380,0002026-03-31
Virtus Opportunities Trust-Virtus KAR Emerging Markets Small-Cap Fund1,199,4742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALFRYAlfresa Holdings Corporation $13.55 +0.00% 10.09 $2.46B 3.10%
APNHYAspen Pharmacare Holdings Limited $8.59 -4.98% -33.17 $3.81B 1.40%
CHSYFChina Medical System Holdings Limited $1.57 +0.00% 17.84 $3.80B 2.55%
CURLFCuraleaf Holdings, Inc. $9.70 -2.07% -24.17 $2.56B 0.00%
DMPHFDermapharm Holding SE $53.00 +0.00% 16.91 $2.63B 1.91%

About Haw Par Corporation Limited

Haw Par Corporation Limited, a company established in 1969 and headquartered in Singapore, conducts a broad range of operations including the manufacturing, marketing, and distribution of healthcare products across Singapore, ASEAN countries, other parts of Asia, and international markets. Its business activities are structured into three main segments: 1. Healthcare: This division primarily focuses on the creation and worldwide distribution of topical analgesic solutions, notably recognized for its popular Tiger Balm and Kwan Loong brands. 2. Investments: This segment is engaged in capital market activities, specifically investing in publicly traded securities. Additionally, it possesses and leases out a significant portfolio of investment properties, which includes 45,324 square meters of commercial and industrial space located in Singapore and Malaysia. 3. Others: This segment delivers leisure and entertainment experiences, prominently featuring oceanariums designed for families and tourists. Beyond these core segments, Haw Par Corporation Limited also offers property leasing services for land, buildings, and office facilities, along with providing management support services.

Haw Par Corporation Limited is headquartered in SG.

Haw Par Corporation Limited (HAWPF) stock trades at $12.58 with a market capitalization of $2.78B. The stock is valued at a price-to-earnings (P/E) ratio of 13.52, price-to-book of 0.84, price-to-sales of 15.61. Over the past 52 weeks the stock has ranged between $9.40 and $14.17, and currently trades 11.2% below its 52-week high. It pays a dividend yielding 1.27%.

On profitability, Haw Par Corporation Limited generates a return on equity (ROE) of 6.34%, return on capital employed of 1.56%, an operating margin of 29.17%, a net profit margin of 115.43%.

Official website: www.hawpar.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides